Just a moment...
Press 'Enter' to add multiple search terms. Rules for Better Search
Use comma for multiple locations.
---------------- For section wise search only -----------------
Accuracy Level ~ 90%
Press 'Enter' after typing page number.
Press 'Enter' after typing page number.
No Folders have been created
Are you sure you want to delete "My most important" ?
NOTE:
Press 'Enter' after typing page number.
Press 'Enter' after typing page number.
Don't have an account? Register Here
Press 'Enter' after typing page number.
Issues: Whether the imported bulk drugs were entitled to customs duty exemption under the relevant exemption notifications and Chapter 99, and whether the later amendment operated retrospectively to extend the benefit.
Analysis: The imported goods were bulk drugs and raw materials, not life-saving drugs or medicines in ready-to-use form. The exemption under the basic notification was subject to mandatory conditions, including execution of a bond and maintenance and production of accounts evidencing use in manufacture for the specified purpose. The amendments to the notification altered the conditions of exemption, but they did not validate a claim made without compliance with those conditions. Chapter 99 covered life-saving drugs and medicines, not the bulk drugs imported for manufacture. The later notification was not treated as conferring retrospective exemption on such bulk drugs.
Conclusion: The imported goods were not entitled to the claimed exemption, and the appeal failed.
Ratio Decidendi: Exemption under a customs notification is available only upon compliance with its mandatory conditions, and bulk drugs used as raw material do not acquire exemption merely because they are intended for manufacture of life-saving medicines or are later referred to in an amending notification.